{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:08:05Z","timestamp":1790611685772,"version":"4.1.0"},"reference-count":20,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej22-0208","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T22:09:42Z","timestamp":1660774182000},"page":"1431-1435","source":"Crossref","is-referenced-by-count":12,"title":["Four cases of Graves\u2019 disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine"],"prefix":"10.1507","volume":"69","author":[{"given":"Shakun","family":"Chaudhary","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Dr Rajendra Prasad Government Medical College Kangra at Tanda, Himachal Pradesh 176001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Dogra","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Dr Rajendra Prasad Government Medical College Kangra at Tanda, Himachal Pradesh 176001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Walia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1 (2022) WHO Coronavirus (COVID-19) Dashboard. World Health Organisation. https:\/\/covid19.who.int\/ accessed on July 5, 2022."},{"key":"2","unstructured":"2 WHO COVID-19 vaccine explainer (2021) AstraZeneca ChAdOx1-S\/nCoV-19 [recombinant] COVID-19 vaccine: 1\u20132."},{"key":"3","unstructured":"3 Hollenberg A, Wiersinga WM (2020) Hyperthyroid disorders. In: Melmed S, Koenig R, Rosen C, Auchus R, Goldfine A (eds) Williams Textbook of Endocrinology (14<sup>th<\/sup>). Elsevier, Philadelphia, USA: 372\u2013373."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Shoenfeld Y, Agmon-Levin N (2011) \u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants. J Autoimmun 36: 4\u20138.","DOI":"10.1016\/j.jaut.2010.07.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, et al. (2020) ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab 34: 101412.","DOI":"10.1016\/j.beem.2020.101412"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Watad A, Bragazzi NL, McGonagle D, Adawi M, Bridgewood C, et al. (2019) Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases. Clin Immunol 203: 1\u20138.","DOI":"10.1016\/j.clim.2019.03.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Harris A, Al Mushref M (2021) Graves\u2019 thyrotoxicosis following SARS-CoV-2 infection. AACE Clin Case Rep 7: 14\u201316.","DOI":"10.1016\/j.aace.2020.12.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Brancatella A, Ricci D, Viola N, Sgr\u00f2 D, Santini F, et al. (2020) Subacute thyroiditis after Sars-COV-2 Infection. J Clin Endocrinol Metab 105: dgaa276.","DOI":"10.1210\/clinem\/dgaa276"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 \u0130remli BG, \u015eendur SN, \u00dcnl\u00fct\u00fcrk U (2021) Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: post-vaccination ASIA syndrome. J Clin Endocrinol Metab 106: 2600\u20132605.","DOI":"10.1210\/clinem\/dgab373"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Das L, Bhadada SK, Sood A (2022) Post-COVID-vaccine autoimmune\/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis. J Endocrinol Invest 45: 465\u2013467.","DOI":"10.1007\/s40618-021-01681-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sriphrapradang C, Shantavasinkul PC (2021) Graves\u2019 disease following SARS-CoV-2 vaccination. Endocrine 74: 473\u2013474.","DOI":"10.1007\/s12020-021-02902-y"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, S\u00e1nchez Valadez TI, et al. (2021) Two cases of Graves\u2019 disease following SARS-CoV-2 vaccination: an autoimmune\/inflammatory syndrome induced by adjuvants. Thyroid 31: 1436\u20131439.","DOI":"10.1089\/thy.2021.0142"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Zettinig G, Krebs M (2022) Two further cases of Graves\u2019 disease following SARS-Cov-2 vaccination. J Endocrinol Invest 45: 227\u2013228.","DOI":"10.1007\/s40618-021-01650-0"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al. (2016) American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26: 1343\u20131421.","DOI":"10.1089\/thy.2016.0229"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Chee YJ, Liew H, Hoi WH, Lee Y, Lim B, et al. (2022) SARS-CoV-2 mRNA vaccination and Graves\u2019 disease: a report of 12 cases and review of the literature. J Clin Endocrinol Metab 107: e2324\u2013e2330.","DOI":"10.1210\/clinem\/dgac119"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Rubinstein TJ (2021) Thyroid eye disease following COVID-19 vaccine in a patient with a history Graves\u2019 disease: a case report. Ophthalmic Plast Reconstr Surg 37: e221\u2013e223.","DOI":"10.1097\/IOP.0000000000002059"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Chin YH, Ng CH, Lee MH, Koh JWH, Kiew J, et al. (2020) Prevalence of thyroid eye disease in Graves\u2019 disease: a meta-analysis and systematic review. Clin Endocrinol(Oxf) 93: 363\u2013374.","DOI":"10.1111\/cen.14296"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ruggeri RM, Campenn\u00ec A, Deandreis D, Siracusa M, Tozzoli R, et al. (2021) SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol 17: 737\u2013759.","DOI":"10.1080\/1744666X.2021.1932467"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kanduc D, Shoenfeld Y (2020) On the molecular determinants of the SARS-CoV-2 attack. Clin Immunol 215: 108426.","DOI":"10.1016\/j.clim.2020.108426"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Sriphrapradang C (2021) Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves\u2019 disease. Endocrine 74: 226\u2013227.","DOI":"10.1007\/s12020-021-02879-8"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/12\/69_EJ22-0208\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T03:12:57Z","timestamp":1672456377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/12\/69_EJ22-0208\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0208","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ22-0208"}}